Cleansing Device for the Treatment of Scalp and Hair Conditions
Launched by UNIVERSITY OF MINNESOTA · Mar 31, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a special device that combines a WaterPik and a brush to help improve the health of the scalp and hair. The study focuses on people with conditions like dandruff, seborrheic dermatitis (a type of skin irritation on the scalp), or hair loss. The goal is to see if using this device can make a positive difference in these scalp conditions.
To participate, you must be between the ages of 65 and 74 and have one of the scalp conditions mentioned above, as determined by a dermatologist. If you are a woman who could become pregnant, you will need to use two reliable methods of birth control during the study because the device uses ultrasound technology, which is not recommended for pregnant women. Participants will receive the device and will be asked to use it as directed to help assess its effectiveness. It's important to note that this study is currently looking for volunteers, so if you think you might be eligible, it could be a great opportunity to explore a new treatment option for your scalp health.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Participants must qualify for one of the following scalp conditions based on clinical opinion of a board-certified dermatologist: healthy scalp, dandruff, seborrheic dermatitis, or hair loss disease
- • All Women of Child Bearing Potential must indicate use of two of the following contraceptive methods. The WaterPik device uses an ultrasonic technology which includes ultrasound. Unnecessary ultrasound is not recommended for pregnant women.
- • Combined (estrogen and progestogen containing) hormonal contraception associated with inhibition of ovulation (oral, intravaginal, or transdermal)
- • Progestogen-only hormonal contraception associated with inhibition of ovulation (oral, injectable, or implantable)
- • Intrauterine device (IUD)
- • Intraurerine hormone-releasing system (IUS)
- • Vasectomized partner
- • Sexual abstinence
- • Barrier method, such as a condom
- Exclusion Criteria:
- • Non-English speaking
- • Exclusion related to pregnancy, lactation, or plans to become pregnant over the course of the study (based on self-report from the participant)
- • Current clinical condition that, in the opinion of the site investigator, would interfere with adherence to study requirements
About University Of Minnesota
The University of Minnesota is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a focus on interdisciplinary collaboration, the university leverages its extensive resources and expertise to conduct cutting-edge studies aimed at improving patient outcomes and addressing critical health challenges. Its robust clinical trial program emphasizes ethical standards, patient safety, and scientific rigor, contributing to the development of novel therapies and interventions that enhance medical practice and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Minneapolis, Minnesota, United States
Patients applied
Trial Officials
Ronda Farah, MD
Principal Investigator
University of Minnesota Medical School Department of Dermatology
Maria Hordinsky, MD
Principal Investigator
University of Minnesota Medical School Department of Dermatology
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials